Thank you gpuppy. If it's true that poorly doing patients were leaving for I/O, it's the perfect explanation. But a trial like this is a total joke, you can't win. Will the FDA take this into consideration? Has anyone seen this situation in other trials? But the positive is that this cannot happen in a Bavi/IO trial (if we ever do one) Bought some more but just because it's trading at a big discount to NAV. Kind regards Danny